IL2 and gastric cancer: Promotes production of anti-inflammatory cytokines (IL-2, IL-4 and IL-10), inhibits secretion of pro-inflammatory cytokines (IL-6 and TNF-α), enhances natural killer cells and cytotoxic T lymphocytes (CTL) killing activity and increased phagocytosis of gastric cancer rat macrophages